Press Releases

Press Releases

    Date Title View
    12/05/11
    Summary ToggleHorizon Pharma Announces Launch of DUEXIS(R) (Ibuprofen/Famotidine) 800 mg/26.6 mg in the United States
    11/29/11
    Summary ToggleHorizon Pharma Announces U.S. Food and Drug Administration Acceptance of LODOTRA(R) New Drug Application for Review for the Treatment of Rheumatoid Arthritis
    11/14/11
    Summary ToggleHorizon Pharma Reports Third Quarter 2011 Financial Results and Provides DUEXIS Launch Update
    11/14/11
    Summary ToggleHorizon Pharma and Sanofi Announce FDA Approval of DUEXIS(R) Commercial Manufacturing Facility
    10/21/11
    Summary ToggleHorizon Pharma to Ring the NASDAQ Stock Market Closing Bell on October 24, 2011
    10/13/11
    Summary ToggleHorizon Pharma Receives U.S. Patent Allowance for DUEXIS(R) in the United States
    09/30/11
    Summary ToggleHorizon Pharma Adds Two New Biopharmaceutical Executives to Its Board of Directors
    09/28/11
    Summary ToggleHorizon Pharma Submits New Drug Application for LODOTRA(R) for the Treatment of Rheumatoid Arthritis
    09/14/11
    Summary ToggleHorizon Pharma to Present at the JMP Securities Healthcare Conference
    09/06/11
    Summary ToggleHorizon Pharma Receives U.S. Patent Allowance for DUEXIS(R) (Ibuprofen/Famotidine)
    Displaying 1 - 10 of 14 results